Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, No. 155 NanJing North Road, Shenyang, China.
College of Life Science, Liaoning University, 66 Chongshan Road, Shenyang, 110036, People's Republic of China.
J Transl Med. 2021 Jun 8;19(1):251. doi: 10.1186/s12967-021-02918-y.
N6-methyl-adenosine (m6A) is one of the most common internal modifications on RNA molecules present in mammalian cells. Deregulation of m6A modification has been recently implicated in many types of human diseases. Therefore, m6A modification has become a research hotspot for its potential therapeutic applications in the treatment of various diseases. The immune system mostly involves different types of immune cells to provide the first line of defense against infections. The immunoregulatory network that orchestrate the immune responses to new pathogens plays a pivotal role in the development of the disease. And m6A modification has been demonstrated to be a major post-transcriptional regulator of immune responses in cells. In this review, we summarize the participants involved in m6A regulation and try to reveal how m6A modification affects the immune responses via changing the immunoregulatory networks.
N6-甲基腺苷(m6A)是哺乳动物细胞中 RNA 分子上最常见的内部修饰之一。m6A 修饰的失调最近被牵连到许多类型的人类疾病中。因此,m6A 修饰因其在治疗各种疾病中的潜在治疗应用而成为研究热点。免疫系统主要涉及不同类型的免疫细胞,为抵御感染提供第一道防线。协调对新病原体的免疫反应的免疫调节网络在疾病的发展中起着关键作用。并且 m6A 修饰已被证明是细胞中免疫反应的主要转录后调节剂。在这篇综述中,我们总结了参与 m6A 调节的参与者,并试图揭示 m6A 修饰如何通过改变免疫调节网络来影响免疫反应。
J Transl Med. 2021-6-8
Mol Cancer. 2020-2-28
Front Oncol. 2021-10-15
Cell Commun Signal. 2022-9-9
Cancer Gene Ther. 2024-9
Virol J. 2019-11-11
Cell Death Dis. 2021-3-19
Mol Ther Nucleic Acids. 2022-1-21
Biomolecules. 2024-8-22
J Hematol Oncol. 2019-11-22
Hereditas. 2024-11-18
Biomolecules. 2024-8-22
Cell Biochem Biophys. 2024-12
Cancer Gene Ther. 2024-9
Cancer Cell Int. 2020-7-28
Cell Signal. 2020-5
Cell Death Dis. 2020-1-20
PLoS One. 2020-1-15